Medicinova MNOV
NASDAQ MNOV
$1.39 +0.03 (+2.21%)
As of: Aug 21, 2026 · 3:59 PM EDT

Medicinova (MNOV) Return on Sales (2012 - 2026)

Medicinova (MNOV) posted quarterly Return on Sales of 0.18% for Q4 2025, up 29.37% quarter-over-quarter from 0.26% in Q3 2025.

Medicinova (MNOV) Return on Sales (2012 - 2026) Analysis & Trends

Medicinova (MNOV) has reported Return on Sales for 7 consecutive years, with 0.18% the latest figure, recorded in Q4 2025.

  • In Q4 2025, Return on Sales changed N/A year-over-year to 0.18%; the TTM figure through Dec 2025 stood at 0.31% (changed N/A YoY), while the FY2025 annual figure was 0.23%, changed N/A from the prior year.
  • Return on Sales rose to 0.18% in Q4 2025 per MNOV's latest filing, from 0.26% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.0% in Q1 2021 and bottomed at 1.95% in Q2 2021.
  • Historically, Return on Sales has averaged 0.54% across 3 years, with a median of 0.26% in 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.00%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 0.00%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.00%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.00%
10 Medicinova 68.42 Mn 68.42 Mn 317,759.00 -0.05%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.05%
Dec 31, 2025 -0.18%
Sep 30, 2025 -0.26%
Jun 30, 2025 -0.27%
Dec 31, 2023 -0.90%
Sep 30, 2023 -0.01%
Dec 31, 2021 -0.03%
Sep 30, 2021 -1.25%
Jun 30, 2021 -1.95%
Mar 31, 2021 0.00%
Mar 31, 2015 -0.02%
Mar 31, 2014 -0.01%
Dec 31, 2013 0.01%
Sep 30, 2013 -2.66%
Jun 30, 2013 -108.41%
Mar 31, 2013 -8.06%
Dec 31, 2012 -0.73%
Sep 30, 2012 -0.28%
Jun 30, 2012 -0.05%
Mar 31, 2012 -0.20%